Power Law company profile

Areteia Therapeutics

Biotech & Life Sciences · Chapel Hill, United States · Founded 2021 Unicorn

Oral eosinophil maturation inhibitor for inflammatory airway diseases

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

11 investors on Areteia Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 11 investors entered at this stage

Saturn Partners

Population Health Partners

Access Biotechnology

Activate Venture Partners

Maverick Capital

Marshall Wace

Bain Capital Life Sciences

Sanofi

Viking Global Investors

ARCH Venture Partners

Global footprint

Where Areteia Therapeutics has talent and traffic

Workforce by country

2 countries with
team presence

🇺🇸 United States93.5%

🇬🇧 United Kingdom6.5%

2 countries shown

Web traffic by country

2K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Patent intelligence

$13M patent portfolio · 17 active families

Estimated portfolio value

$13M

0.77% of valuation · 2.4× smaller than top peer Dynavax Technologies ($32M)

17 active patent families

Where Areteia Therapeutics innovates DexpramipexoleBenzothiazoleGranulocytic cellsPharmaceutical medicineEosinophil

Where Areteia Therapeutics concentrates vs peers

Each axis is a top-10 topic across Areteia Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Areteia Therapeutics

An AI-synthesized read of the highest-engagement posts about Areteia Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Areteia Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles